The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Extracorporeal Life Support Technology Market Research Report 2025
Synopsis
Global Extracorporeal Life Support Technology market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Extracorporeal Life Support Technology market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Extracorporeal Life Support Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Medtronic
MAQUET Holding
Microport Scientific
Sorin Group
Nipro Medical
Terumo Cardiovascular Systems
MedosMedizintechnik
Getinge
BiVACOR
SynCardia
Jarvik Heart
CARMAT
AbioMed
Segment by Type
Arterial-venous (VA-ECMO)
Veno-venous (VV-ECMO)
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Extracorporeal Life Support Technology report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Global Extracorporeal Life Support Technology market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Extracorporeal Life Support Technology market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Extracorporeal Life Support Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Medtronic
MAQUET Holding
Microport Scientific
Sorin Group
Nipro Medical
Terumo Cardiovascular Systems
MedosMedizintechnik
Getinge
BiVACOR
SynCardia
Jarvik Heart
CARMAT
AbioMed
Segment by Type
Arterial-venous (VA-ECMO)
Veno-venous (VV-ECMO)
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Extracorporeal Life Support Technology report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extracorporeal Life Support Technology Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Arterial-venous (VA-ECMO)
1.2.3 Veno-venous (VV-ECMO)
1.3 Market by Application
1.3.1 Global Extracorporeal Life Support Technology Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Extracorporeal Life Support Technology Market Perspective (2018-2029)
2.2 Extracorporeal Life Support Technology Growth Trends by Region
2.2.1 Global Extracorporeal Life Support Technology Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Extracorporeal Life Support Technology Historic Market Size by Region (2018-2023)
2.2.3 Extracorporeal Life Support Technology Forecasted Market Size by Region (2024-2029)
2.3 Extracorporeal Life Support Technology Market Dynamics
2.3.1 Extracorporeal Life Support Technology Industry Trends
2.3.2 Extracorporeal Life Support Technology Market Drivers
2.3.3 Extracorporeal Life Support Technology Market Challenges
2.3.4 Extracorporeal Life Support Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Extracorporeal Life Support Technology Players by Revenue
3.1.1 Global Top Extracorporeal Life Support Technology Players by Revenue (2018-2023)
3.1.2 Global Extracorporeal Life Support Technology Revenue Market Share by Players (2018-2023)
3.2 Global Extracorporeal Life Support Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Extracorporeal Life Support Technology Revenue
3.4 Global Extracorporeal Life Support Technology Market Concentration Ratio
3.4.1 Global Extracorporeal Life Support Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extracorporeal Life Support Technology Revenue in 2022
3.5 Extracorporeal Life Support Technology Key Players Head office and Area Served
3.6 Key Players Extracorporeal Life Support Technology Product Solution and Service
3.7 Date of Enter into Extracorporeal Life Support Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Extracorporeal Life Support Technology Breakdown Data by Type
4.1 Global Extracorporeal Life Support Technology Historic Market Size by Type (2018-2023)
4.2 Global Extracorporeal Life Support Technology Forecasted Market Size by Type (2024-2029)
5 Extracorporeal Life Support Technology Breakdown Data by Application
5.1 Global Extracorporeal Life Support Technology Historic Market Size by Application (2018-2023)
5.2 Global Extracorporeal Life Support Technology Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Extracorporeal Life Support Technology Market Size (2018-2029)
6.2 North America Extracorporeal Life Support Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Extracorporeal Life Support Technology Market Size by Country (2018-2023)
6.4 North America Extracorporeal Life Support Technology Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Extracorporeal Life Support Technology Market Size (2018-2029)
7.2 Europe Extracorporeal Life Support Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Extracorporeal Life Support Technology Market Size by Country (2018-2023)
7.4 Europe Extracorporeal Life Support Technology Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Extracorporeal Life Support Technology Market Size (2018-2029)
8.2 Asia-Pacific Extracorporeal Life Support Technology Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Extracorporeal Life Support Technology Market Size by Region (2018-2023)
8.4 Asia-Pacific Extracorporeal Life Support Technology Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Extracorporeal Life Support Technology Market Size (2018-2029)
9.2 Latin America Extracorporeal Life Support Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Extracorporeal Life Support Technology Market Size by Country (2018-2023)
9.4 Latin America Extracorporeal Life Support Technology Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Extracorporeal Life Support Technology Market Size (2018-2029)
10.2 Middle East & Africa Extracorporeal Life Support Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Extracorporeal Life Support Technology Market Size by Country (2018-2023)
10.4 Middle East & Africa Extracorporeal Life Support Technology Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Extracorporeal Life Support Technology Introduction
11.1.4 Medtronic Revenue in Extracorporeal Life Support Technology Business (2018-2023)
11.1.5 Medtronic Recent Development
11.2 MAQUET Holding
11.2.1 MAQUET Holding Company Detail
11.2.2 MAQUET Holding Business Overview
11.2.3 MAQUET Holding Extracorporeal Life Support Technology Introduction
11.2.4 MAQUET Holding Revenue in Extracorporeal Life Support Technology Business (2018-2023)
11.2.5 MAQUET Holding Recent Development
11.3 Microport Scientific
11.3.1 Microport Scientific Company Detail
11.3.2 Microport Scientific Business Overview
11.3.3 Microport Scientific Extracorporeal Life Support Technology Introduction
11.3.4 Microport Scientific Revenue in Extracorporeal Life Support Technology Business (2018-2023)
11.3.5 Microport Scientific Recent Development
11.4 Sorin Group
11.4.1 Sorin Group Company Detail
11.4.2 Sorin Group Business Overview
11.4.3 Sorin Group Extracorporeal Life Support Technology Introduction
11.4.4 Sorin Group Revenue in Extracorporeal Life Support Technology Business (2018-2023)
11.4.5 Sorin Group Recent Development
11.5 Nipro Medical
11.5.1 Nipro Medical Company Detail
11.5.2 Nipro Medical Business Overview
11.5.3 Nipro Medical Extracorporeal Life Support Technology Introduction
11.5.4 Nipro Medical Revenue in Extracorporeal Life Support Technology Business (2018-2023)
11.5.5 Nipro Medical Recent Development
11.6 Terumo Cardiovascular Systems
11.6.1 Terumo Cardiovascular Systems Company Detail
11.6.2 Terumo Cardiovascular Systems Business Overview
11.6.3 Terumo Cardiovascular Systems Extracorporeal Life Support Technology Introduction
11.6.4 Terumo Cardiovascular Systems Revenue in Extracorporeal Life Support Technology Business (2018-2023)
11.6.5 Terumo Cardiovascular Systems Recent Development
11.7 MedosMedizintechnik
11.7.1 MedosMedizintechnik Company Detail
11.7.2 MedosMedizintechnik Business Overview
11.7.3 MedosMedizintechnik Extracorporeal Life Support Technology Introduction
11.7.4 MedosMedizintechnik Revenue in Extracorporeal Life Support Technology Business (2018-2023)
11.7.5 MedosMedizintechnik Recent Development
11.8 Getinge
11.8.1 Getinge Company Detail
11.8.2 Getinge Business Overview
11.8.3 Getinge Extracorporeal Life Support Technology Introduction
11.8.4 Getinge Revenue in Extracorporeal Life Support Technology Business (2018-2023)
11.8.5 Getinge Recent Development
11.9 BiVACOR
11.9.1 BiVACOR Company Detail
11.9.2 BiVACOR Business Overview
11.9.3 BiVACOR Extracorporeal Life Support Technology Introduction
11.9.4 BiVACOR Revenue in Extracorporeal Life Support Technology Business (2018-2023)
11.9.5 BiVACOR Recent Development
11.10 SynCardia
11.10.1 SynCardia Company Detail
11.10.2 SynCardia Business Overview
11.10.3 SynCardia Extracorporeal Life Support Technology Introduction
11.10.4 SynCardia Revenue in Extracorporeal Life Support Technology Business (2018-2023)
11.10.5 SynCardia Recent Development
11.11 Jarvik Heart
11.11.1 Jarvik Heart Company Detail
11.11.2 Jarvik Heart Business Overview
11.11.3 Jarvik Heart Extracorporeal Life Support Technology Introduction
11.11.4 Jarvik Heart Revenue in Extracorporeal Life Support Technology Business (2018-2023)
11.11.5 Jarvik Heart Recent Development
11.12 CARMAT
11.12.1 CARMAT Company Detail
11.12.2 CARMAT Business Overview
11.12.3 CARMAT Extracorporeal Life Support Technology Introduction
11.12.4 CARMAT Revenue in Extracorporeal Life Support Technology Business (2018-2023)
11.12.5 CARMAT Recent Development
11.13 AbioMed
11.13.1 AbioMed Company Detail
11.13.2 AbioMed Business Overview
11.13.3 AbioMed Extracorporeal Life Support Technology Introduction
11.13.4 AbioMed Revenue in Extracorporeal Life Support Technology Business (2018-2023)
11.13.5 AbioMed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
